Cat. No.: X23-10-ZQ407
JAK inhibitor PF-03394197, Purity ≥98%
Synonym: OCLACITINIB; 1208319-26-9; PF-03394197; PF-03394197(Oclacitinib); JAKI; Oclacitinib [USAN]; N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide; JAK inhibitor
- MDL: MFCD25976611
- CAS Number: 1208319-26-9
- Compound CID: 44631938
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
PF-03394197 is an available JAK small molecule inhibitor with potential antineoplastic activity.
Molecular Formula
C15H23N5O2S
Identity
Confirmed by NMR/HPLC/MS.
Applications
PF-03394197 is utilized to study JAK kinase inhibition with a focus on JAK1.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links